Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.38 |
| ▸ | CHRNA1 | P02708 | 2/20 | 0.38 |
| ▸ | CHRNG | P07510 | 2/20 | 0.38 |
| ▸ | CHRNB1 | P11230 | 2/20 | 0.38 |
| ▸ | CHRND | Q07001 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | NPY1R | P25929 | 1/20 | 0.37 |
| ▸ | GRIA1 | P42261 | 2/20 | 0.35 |
| ▸ | NAMPT | P43490 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26066952 | 0.79 | ALDH1A1 (0.39) | KIF11SMN1; SMN2TSHRRECQL | |
| SCHEMBL7263720 | 0.74 | KIF11 (0.65) | KIF11SMN1; SMN2TSHRLMNA | |
| SCHEMBL7268298 | 0.74 | KIF11 (0.65) | KIF11SMN1; SMN2TSHRLMNA | |
| SCHEMBL7268289 | 0.73 | KIF11 (0.67) | KIF11SMN1; SMN2TSHR | |
| SCHEMBL20017289 | 0.71 | MEN1 (0.41) | SMN1; SMN2TSHRRECQLLMNA | |
| SCHEMBL7269694 | 0.71 | KIF11 (0.59) | KIF11SMN1; SMN2LMNA | |
| SCHEMBL7262278 | 0.71 | KIF11 (0.59) | KIF11SMN1; SMN2LMNA | |
| SCHEMBL18475596 | 0.70 | KIF11 (0.54) | KIF11SMN1; SMN2 | |
| SCHEMBL3136435 | 0.69 | KIF11 (0.61) | KIF11CHRNA1CHRNGCHRNB1CHRND | |
| SCHEMBL20107340 | 0.69 | SMN1; SMN2 (0.56) | SMN1; SMN2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230270867-A1 | CONJUGATE IN WHICH FL118 DRUG IS LINKED TO ACID-SENSITIVE LINKER, AND IMMUNOCONJUGATE USING SAME | PINOTBIO, INC. (KR) | 2023-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230270867-A1 | CONJUGATE IN WHICH FL118 DRUG IS LINKED TO ACID-SENSITIVE LINKER, AND IMMUNOCONJUGATE USING SAME | SLC46A1, SLC47A1, FOLR1 | KIF11 1946/4885SMN1; SMN2 4568/4885TRPV1 3165/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.